Similarly, AhR agonists demonstrated favorable therapeutic effects in an imiquimod (IMQ)-induced mouse model (Colonna, 2014), while the AhR antagonist CH-223191 exacerbates psoriasis-related gene expression in patient biopsies by blocking the AhR pathway (Um et al., 2020). This evidence concerns the gene AHR and psoriasis.